1. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study. (18th September 2020) Authors: Yu, Li; Shi, Menghan; Cai, Qingqing; Strati, Paolo; Hagemeister, Fredrick; Zhai, Qiongli; Li, Ling; Fang, Xiaosheng; Li, Jianyong; Sun, Ruifang; Zhang, Shanxiang; Yang, Hanjin; Wang, Zhaoming; Qian, Wenbin; Iwaki, Noriko; Sato, Yasuharu; Zhang, Lu; Li, Jian; Oksenhendler, Eric; Xu‐Monette, Zijun Y. Journal: Oncologist Issue: Volume 25:Number 11(2020) Page Start: 963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma. (21st July 2022) Authors: Strati, Paolo; Coleman, Morton; Champion, Rebecca; Ma, Shuo; Patti, Caterina; Levy, Moshe Y.; Lossos, Izidore S.; Geethakumari, Praveen Ramakrishnan; Lam, Selay; Calvo, Roser; Higgins, Kara; Budde, Lihua E. Journal: British journal of haematology Issue: Volume 199:Number 1(2022) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia. Issue 6 (June 2015) Authors: Strati, Paolo; Tong, Wei-Gang; Vitale, Candida; Wierda, William G.; O'Brien, Susan; Brown, Jennifer R.; Weng, Wen-Kai; Kipps, Thomas; Keating, Michael J.; Ferrajoli, Alessandra Journal: Leukemia & lymphoma Issue: Volume 56:Issue 6(2015:Jun.) Page Start: 1878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. Issue 1 (2nd January 2022) Authors: Cherng, Hua-Jay J.; Chuang, Hubert H.; Steiner, Raphael; Fayad, Luis; Strati, Paolo; Nair, Ranjit; Hagemeister, Fredrick; Nastoupil, Loretta J.; Lee, Hun Ju; Neelapu, Sattva S.; Flowers, Christopher R.; Samaniego, Felipe; Rodriguez, Maria; Macapinlac, Homer A.; Feng, Lei; Westin, Jason Journal: Leukemia & lymphoma Issue: Volume 63:Issue 1(2022) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia. Issue 17 (5th September 2019) Authors: Strati, Paolo; O'Brien, Susan M. Journal: Oncology times Issue: Volume 41:Issue 17(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CAR T-cells and macrophages in large B-cell lymphoma: impact on toxicity and efficacy. Issue 4 (21st March 2023) Authors: Al Zaki, Ajlan; McCurry, Dustin; Strati, Paolo Journal: Leukemia & lymphoma Issue: Volume 64:Issue 4(2023) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia. (7th April 2017) Authors: Strati, Paolo; Parikh, Sameer A.; Chaffee, Kari G; Achenbach, Sara J.; Slager, Susan L.; Call, Timothy G.; Ding, Wei; Jelinek, Diane F.; Hanson, Curtis A.; Kay, Neil E.; Shanafelt, Tait D. Journal: British journal of haematology Issue: Volume 178:Number 1(2017) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?. Issue 3 (March 2021) Authors: Gudiol, Carlota; Lewis, Russell E; Strati, Paolo; Kontoyiannis, Dimitrios P Journal: Lancet Issue: Volume 8:Issue 3(2021) Page Start: e216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia. Issue 2 (28th January 2019) Authors: Strati, Paolo; Gabutti, Cristina; Thompson, Philip A.; Kontoyiannis, Dimitrios P.; Ferrajoli, Alessandra Journal: Leukemia & lymphoma Issue: Volume 60:Issue 2(2019) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax. Issue 5 (16th April 2021) Authors: Marques-Piubelli, Mario L.; Schlette, Ellen J.; Khoury, Joseph D.; Furqan, Fateeha; Vega, Francisco; Soto, Luisa M. Solis; Wistuba, Ignacio I.; Wierda, William G.; Konopleva, Marina; Ferrajoli, Alessandra; Strati, Paolo Journal: Leukemia & lymphoma Issue: Volume 62:Issue 5(2021) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗